Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Feb 17;24:55. doi: 10.1186/s13054-020-2763-4

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s). 2020

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

PMC Copyright notice

Fig. 2 — Meropenem plasma and ELF concentration-time profiles. Meropenem plasma and ELF concentration time profiles of patients receiving a loading dose of 2000 mg i.v followed by a maintenance dose of 1 g q8h and 2 g q8h i.v. Intensive sampling was performed after the second day of treatment. A statistically significant difference was observed in plasma concentrations at any time points between the two groups (meropenem plasma concentrations of 12.9 (8.4) vs 23.0 (12.8) at pre-dose; 13.4 (7.3) vs 23.9 (16.7) at 1.5 h; 13.3 (8.3) vs 21.4 (15.5) at 3 h; 11.7 (8.2) vs 22.4 (15.3) at 6 h, and 12.3 (9.1) vs 18.9 (17.4) at 8 h, in the 1 g/8 h and 2 g/8 h groups, respectively).